Login / Signup

Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis.

Jiahui ZhuJia LiuZiwei BaoHong CaoSainan WangXuliang LiZhu NingSven HoffnerYi HuLina Davies Forsman
Published in: Tuberculosis (Edinburgh, Scotland) (2023)
Acquired resistance to isoniazid and/or pyrazinamide during TAT for DST was associated with prolonged time to SCC as well as treatment failure.
Keyphrases
  • mycobacterium tuberculosis
  • pulmonary tuberculosis
  • adverse drug
  • combination therapy
  • hepatitis c virus
  • hiv aids
  • replacement therapy